Trials / Completed
CompletedNCT00767702
Use of Population Descriptors in Human Genetic Research
Exploring the Use of Population Descriptors in Human Genetic Research
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 18 (actual)
- Sponsor
- National Human Genome Research Institute (NHGRI) · NIH
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
This study will explore scientists opinions and practices regarding the use of population descriptors (e.g., race, ethnicity, ancestry, geography and nationality) to describe a research study population. It will collect genetic researchers opinions, understandings and experiences studying human genetics and genetic variation. Scientists who are a principal investigator or co-principal investigator n a human genetic or genomic study of a common disease with at least preliminary data that uses population descriptors may be eligible for the study. Participants are asked to think about their study populations and how they are described in their research. They participate in two audio-taped semi-structured interviews that last from about 90 to 120 minutes. They may also participate in one or both of the following optional study components: * A third semi-structured interview that explores implementing a new method of describing study populations in data analysis. * 2 to 3 days of lab observation, in which a member of the study research team meets the lab members, observes daily activities and attends lab meetings.
Detailed description
The usefulness of social and political population labels, including those based on race, ethnicity, geographic location, ancestry, and nationality, in science and medicine is a topic of heated debate. The discussion is significant not only for defining rigorous scientific study designs, but for influencing how scientists and the broader society conceptualize, discuss, and react to human difference. Misuse of population descriptors in genetic and genomic research has the potential to perpetuate misinformation, stigmatize certain groups and simplify the complex relationships between individual identity, genetics, and health. With such potential harms in mind, National Institutes of Health guidelines to use the Office of Management and Budget categories of race and ethnicity to monitor inclusion in clinical trials and evaluate potential differences in the safety and efficacy of interventions have been questioned. As increasing attention is given to the implications of human genetic variation on disease and health, actively engaging with scientists may help to identify a lexicon for discussing human genetic variation that is scientifically sound and socially and politically meaningful. We aim to conduct a pilot qualitative study of genetic researchers, exploring their use of population descriptors in human genetic research, including an experiment in which they have the opportunity to describe and group their study populations in a new way. We use qualitative methods to capture researchers' opinions and practices as they think critically about the use of population labels in their studies. Understanding individual scientists opinions about the strengths and weaknesses of different classifications in various contexts will provide important data to help define and facilitate appropriate use of population descriptors in human genetic research.
Conditions
Timeline
- Start date
- 2008-09-18
- Completion
- 2012-08-08
- First posted
- 2008-10-07
- Last updated
- 2019-11-06
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00767702. Inclusion in this directory is not an endorsement.